11/20/25 16:42 | 11/20/25 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | TX | O | EVP Fina | P | 16 | 0.8000 | 0 | 20 | 999% | 20 | D | | | | | | | | | | | | | | |
5/31/22 17:13 | 5/31/22 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | TX | O | EVP Fina | P | 5 | 0.1800 | 0 | 28 | 23 | 148 | D | | | | | | | | | | | | | | |
3/9/22 16:03 | 3/3/22 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | TX | O | EVP Fina | P | 30 | 0.3910 | 0 | 76 | 224 | 110 | D | | | | | | | | | | | | | | |
8/18/20 08:35 | 8/17/20 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | TX | O | EVP Fina | P | 5 | 1.00 | 0 | 5 | 71 | 12 | D | | | | | | | | | | | | | | |
2/20/20 16:07 | 2/19/20 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | TX | O | EVP Fina | P | 2 | 0.9500 | 0 | 2 | 40 | 7 | D | | | | | | | | | | | | | | |
2/13/20 17:57 | 2/13/20 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | TX | O | EVP Fina | P | 4 | 0.8590 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
10/28/13 21:51 | 10/24/13 | ADXS | Advaxis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rosenblum Mark J | NJ | O | CFO | P.d | 48 | 4.00 | 1 | 12 | 110 | 23 | D | -80 | -37 | -58 | 8 | -43 | -21 | -28 | 0 | 4 | -1 | 1 | 31 | -34 | -10 |
11/23/05 12:13 | 11/21/05 | HMBT | Hemobiotech Inc | | Health | BioPrd | Biological Products, (No Diag | Rosenblum Mark J | TX | O | CFO | P.d | 3 | 1.50 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |